The I-SPY 2 Breast Cancer Trial: How Clinical Trials May Be Changing
In “adaptive” clinical trial design, the goal is to identify as rapidly as possible new drug therapies that show a likelihood of being successful in specific patient populations.
Exploring progress in cancer research from the patient perspective
In “adaptive” clinical trial design, the goal is to identify as rapidly as possible new drug therapies that show a likelihood of being successful in specific patient populations.
My top five takeaways from the 2013 San Antonio Breast Cancer Symposium.
A new set of findings from The Cancer Genome Atlas project looks at cancer genome sequencing in a different way–comparing mutations across types of cancer.
“The Truth in Small Doses” by Clifton Leaf provides valuable insights into changes that need to be made in the cancer research “culture” so that we can get on track toward finding new treatments that save more lives.